Skip to content
DataLookout
Menu

MACH3NCT07944677

Metabolism And Diet for Improving Kidney Cancer Health (MACH3)

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Feasibility of Recruitment: Percentage of Participants That Consent to Participate and Meet Eligibility Criteria
Timeframe: Baseline
Feasibility of Retention and Adherence: Percentage of Participants Who Adhere to and Complete the Intervention and Data Collection at All Time Points.
Timeframe: Up to 12 weeks
Acceptability: Percentage of Participants Who Report Satisfaction with the Intervention
Timeframe: Up to 12 weeks

Secondary (15)

Overall Response Rate (ORR)
Number of Participants Experiencing Adverse Events (AEs)
Change in Physical Function (Handgrip Strength)
Change in Diet As Assessed by the Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)
Change in Physical Activity As Measured By Scores on the Godin Leisure Time Exercise Questionnaire
Show 10 moreShow less
Change in Quality of Life As Measured By Scores on the PROMIS-29 Questionnaire
Change in Sleep Quality as Assessed by the Pittsburgh Sleep Quality Index
Change in Physical Activity as Measured By Participant Accelerometry Data, in Steps Per Day
Change in Physical Activity as Measured By Participant Accelerometry Data, in Minutes Per Day
Change in Sleep as Measured By Participant Accelerometry Data, in Minutes Per Night
Change in Sleep as Measured By Participant Percentage of Sleep Efficiency
Change in Sleep as Measured By Participant Accelerometry Data, in Awakenings Per Night
Change in Sleep as Measured By Participant Accelerometry Data, in Minutes
Change in Anthropometrics
Change in Body Composition

Arms and interventions

Arm 1: Intervention (MED+FAST)Experimental

All intervention participants will receive the MED+FAST intervention, which combines time-restricted eating and a Mediterranean diet.

Arm 2: Waitlist Control with Usual CareNo intervention

Participants randomized to the usual care arm will receive standard care with remote digital biomarker monitoring. Control participants will have the option to meet with the study health coach at the end of the 12-week study and will be directed to cancer survivorship services offered at Sylvester for additional support if requested.

Other: Health Coaching, Time-Restricted Eating, Supportive Materials

Dietary supplements: Mediterranean Diet